Yang Donglin
Yang Donglin
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation | Allogeneic Hematopoietic Stem Cell Transplantation; Clinically Significant EBV DNAemia; Epstein-Barr Virus Reactivation | Not yet recruiting | Not applicable | 2026-07-14 | NCT07703657 |